Andere Kunden interessierten sich auch für
![Realizing the Potential of Genomics Across the Continuum of Precision Health Care]( "Realizing the Potential of Genomics Across the Continuum of Precision Health Care")
Realizing the Potential of Genomics Across the Continuum of Precision Health Care23,99 €![Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier]( "Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier")
Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier62,99 €![Relevance of Health Literacy to Precision Medicine]( "Relevance of Health Literacy to Precision Medicine")
Relevance of Health Literacy to Precision Medicine54,99 €![Applying an Implementation Science Approach to Genomic Medicine]( "Applying an Implementation Science Approach to Genomic Medicine")
Applying an Implementation Science Approach to Genomic Medicine48,99 €![Direct-To-Consumer Genetic Testing]( "Direct-To-Consumer Genetic Testing")
Direct-To-Consumer Genetic Testing45,99 €![Challenges and Opportunities for Precision and Personalized Nutrition]( "Challenges and Opportunities for Precision and Personalized Nutrition")
Challenges and Opportunities for Precision and Personalized Nutrition24,99 €![Deriving Drug Discovery Value from Large-Scale Genetic Bioresources]( "Deriving Drug Discovery Value from Large-Scale Genetic Bioresources")
Deriving Drug Discovery Value from Large-Scale Genetic Bioresources50,99 €
Those involved in the drug development process face challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical trial designs that enroll participants based on their genetics represent a potentially disruptive change that could improve patient outcomes, reduce costs associated with drug development, and further realize the goals of precision medicine. On March 8, 2017, the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health of the National Academies of Sciences, Engineering, and Medicine hosted the workshop Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development. Participants examined successes, challenges, and possible best practices for effectively using genetic information in the design and implementation of clinical trials to support the development of precision medicines, including exploring the potential advantages and disadvantages of such trials across a variety of disease areas. This publication summarizes the presentations and discussions from the workshop.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.